Main Market:
North America , South America , Western Europe , Eastern Europe , Eastern Asia , Southeast Asia , Middle East , Africa , Oceania , Worldwide
Business Type:
Manufacturer
Brands:
SYSEYE
No. of Employees:
200~500
Annual Sales:
20000000-30000000
Year Established:
2011
Export p.c:
40% - 50%
Chongqing Bio Newvision Medical Equipment Ltd.
Focusing on the two major public health problems of adolescent myopia and elderly ophthalmology, our company researches new diagnostic and treatment equipment for ophthalmology, develops low-cost applicable technology products, realizes industrialization, reduces the cost of social medical and health system, and serves the strategic needs of national health.The company always adhere to the "high-tech, new vision" for the enterprise development concept.We have a strong technical force, has been awarded 11 patents, and obtained 13,485 quality system certification.Bio has established an efficient marketing team and a perfect after-sales service system to provide medical equipment with the highest cost performance and meticulous service.
We have been committed to independent research and development, constantly launching professional ophthalmic medical devices that meet the needs of different customers, carefully improving product quality, and promoting the intelligent advancement of products with technological innovation. New Vision's product series is suitable for in-hospital diagnosis to digital grading diagnosis, artificial intelligence eye health diagnosis, vision screening, etc., and provides the best ophthalmic diagnostic hardware solutions for hospitals, optometry clinics, physical examinations and other institutions.
2011:
*The predecessor of the compant was established and was approved as "Guangdong Innovation Team"
2015:
*Received USD A round investment from Warwick International （CID)
*Chongqing Beiao Medical Equipment Co., Ltd. acquired Chongqing Bio Medical equipment Co., Ltd. and change
its name to Chongqing Bio Newvision Medical Equipment Co., Ltd.
2017:
*Chongqing Bio NewVision starts product trial production
2018:
*Chongqing Bio Newvision was awarded the title of "National High-tech Enterprise"
*Manual fundus camera approved for market
*Ultrasonic A/B Scanner for Ophthalmology approved for market
*The first fully automatic fundus camera in China approved for market
2019:
*OCT approved for market
*Automatic computer Perimeter approved for market
*Fundus camera obtain FDA certification
*Obtain CE13485 quality management system certification
2020:
*Automatic tonometer approved for market
*Multimodal eye function analysis system approved for market
*Shenzhen Xinyu Vision Technology Co., Ltd. was established, holding Chongqing Bio
NewVision
*Rolocated to a new 4000-square-meter dust-free workshop in Chongqing High-tech
Zone to increase production capacity
*The company was awarded the title of "Intellectual Property Advantage Enterprise"
*Fully automatic fundus camera was selected into the list of excellent domestic medical
equipment
2021:
*The company won the title of "specialized and special new enterprise " in Chongqing
*Projection Perimeter approved for market
2022:
*The company completed the B round of private financing
*Ophthalmic optical biometer approved for market
Chongqing bio new vision established 2011， with 10years experience on ophthalmic instruments. especially in recent years， our group invest much on ophthalmic field to introduce American professors and organize Strong ability R&D team. Now our R&D team ability is strongest in China assuredly. among of 320 staff， there are 80 engineers including optical engineer， electronics engineer，software engineer， mechanical engineer.
Send your inquiry directly to us
